Skip to main content
Premium Trial:

Request an Annual Quote

Labcyte Lands $5.5M in Credit

NEW YORK (GenomeWeb News) – Labcyte said today that it has received a commitment for up to $5.5 million in credit facilities from Hercules Technology Growth Capital.

Labcyte, based in Palo Alto, Calif., makes acoustic liquid handling tools for life science applications, including genomics, proteomics, imaging mass spectrometry, and others.

"Hercules believes the life science research and development market presents a huge opportunity for Labcyte," Kathy Conte, managing director of life sciences at Hercules, said in a statement.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.